PP
GH icon

PDT Partners’s Guardant Health GH Stock Holding History

PDT Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,989
Closed -$4.7M – 563
2025
Q4 		$4.7M Sell
45,989
-4,351
-9% -$389K 0.3% 110
2025
Q3 		$3.15M Sell
50,340
-52,034
-51% -$2.83M 0.2% 176
2025
Q2 		$5.33M Sell
102,374
-105,339
-51% -$4.7M 0.3% 92
2025
Q1 		$8.85M Sell
207,713
-32,760
-14% -$1.41M 0.63% 8
2024
Q4 		$7.35M Buy
240,473
+20,931
+10% +$589K 0.65% 7
2024
Q3 		$5.04M Buy
219,542
+74,957
+52% +$2.12M 0.45% 24
2024
Q2 		$4.18M Buy
144,585
+75,919
+111% +$1.77M 0.4% 52
2024
Q1 		$1.42M Sell
68,666
-21,417
-24% -$459K 0.13% 258
2023
Q4 		$2.44M Sell
90,083
-54,546
-38% -$1.43M 0.27% 113
2023
Q3 		$4.29M Sell
144,629
-15,686
-10% -$552K 0.54% 23
2023
Q2 		$5.74M Buy
160,315
+17,433
+12% +$501K 0.79% 4
2023
Q1 		$3.35M Buy
142,882
+56,723
+66% +$1.62M 0.45% 52
2022
Q4 		$2.34M Buy
+86,159
New +$3.94M 0.38% 63
2021
Q3 		– Sell
-11,000
Closed -$1.37M – 819
2021
Q2 		$1.37M Sell
11,000
-21,216
-66% -$2.85M 0.09% 319
2021
Q1 		$4.92M Sell
32,216
-37,996
-54% -$5.74M 0.35% 48
2020
Q4 		$9.05M Sell
70,212
-12,017
-15% -$1.38M 0.61% 4
2020
Q3 		$9.19M Sell
82,229
-15,471
-16% -$1.42M 0.61% 12
2020
Q2 		$7.93M Buy
+97,700
New +$7.87M 0.54% 47
2020
Q1 		– Sell
-46,377
Closed -$3.62M – 728
2019
Q4 		$3.62M Sell
46,377
-20,595
-31% -$1.48M 0.22% 131
2019
Q3 		$4.28M Buy
+66,972
New +$5.9M 0.25% 126

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's GH Position: Q1 2026 in Review

PDT Partners sold out of Guardant Health (GH) in Q1 2026, closing a stake of 45,989 shares — an estimated $4.7M sold.

PDT Partners first reported a position in GH in Q3 2019 and held it in 20 quarters. The position peaked at $9.19M in Q3 2020. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • PDT Partners reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • PDT Partners sold 45,989 Guardant Health shares in Q1 2026, an estimated $4.7M.
  • PDT Partners first reported a position in Guardant Health in Q3 2019 and held it in 20 quarters.
  • PDT Partners's Guardant Health position peaked at $9.19M in Q3 2020.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.